Sorafenib is a small molecule multi-kinase inhibitor, sorafenib inhibits the proliferation of tumor cells by blocking the activities of Raf-1, B-Raf, and kinase in the Ras/Raf/MEK/ERK signaling pathway. This evidence concerns the gene RAF1 and neoplasm.